New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis
CA 2555656 C · Owner: Centre National De La Recherche Scientifique (Cnrs) · Inventors: Polo, Sophie E.; Almouzni, Genevieve; Theocharis, Stamatios E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a method for assessing the proliferative state of cells in a human or non human biological sample comprising using Chromatin , Assembly Factor-1 (CAF-1 in short) subunits as proliferation markers. Application for cancer prognosis or diagnosis and monitoring tumor response in therapy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 28, 2005 and granted March 28, 2017. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 28, 2025.
- Certificates of supplementary protection extend only drug patents, and it isn't classified as one.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.